S. Poser

15.8k total citations · 2 hit papers
145 papers, 10.5k citations indexed

About

S. Poser is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, S. Poser has authored 145 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 42 papers in Pathology and Forensic Medicine and 32 papers in Neurology. Recurrent topics in S. Poser's work include Prion Diseases and Protein Misfolding (69 papers), Multiple Sclerosis Research Studies (40 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (19 papers). S. Poser is often cited by papers focused on Prion Diseases and Protein Misfolding (69 papers), Multiple Sclerosis Research Studies (40 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (19 papers). S. Poser collaborates with scholars based in Germany, United States and United Kingdom. S. Poser's co-authors include Inga Zerr, Thomas Weber, Hans A. Kretzschmar, Walter Schulz‐Schaeffer, Maurizio Pocchiari, Albert Hofman, Annick Alpérovitch, Robert Will, Martin Zeidler and Otto Windl and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

S. Poser

142 papers receiving 10.1k citations

Hit Papers

A new variant of Creutzfe... 1996 2026 2006 2016 1996 1999 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
S. Poser 7.1k 3.4k 2.4k 1.6k 1.2k 145 10.5k
Matti Haltia 4.6k 0.7× 1.6k 0.5× 2.2k 0.9× 579 0.4× 872 0.7× 204 10.9k
Frank Baas 9.4k 1.3× 2.1k 0.6× 3.2k 1.3× 905 0.5× 278 0.2× 361 21.7k
Walter Schulz‐Schaeffer 8.2k 1.2× 4.3k 1.3× 3.5k 1.4× 238 0.1× 983 0.8× 222 12.7k
James W. Ironside 17.6k 2.5× 8.2k 2.5× 4.0k 1.7× 536 0.3× 1.1k 0.8× 451 23.3k
Salvatore Monaco 2.2k 0.3× 1.3k 0.4× 2.0k 0.8× 1.2k 0.7× 233 0.2× 205 5.8k
Sandra Amor 3.6k 0.5× 4.3k 1.3× 1.4k 0.6× 3.1k 1.9× 257 0.2× 198 12.4k
Etty Benveniste 6.0k 0.8× 5.2k 1.6× 1.2k 0.5× 1.5k 0.9× 302 0.2× 233 18.5k
Jorge Correale 2.2k 0.3× 1.1k 0.3× 1.3k 0.6× 4.0k 2.5× 778 0.6× 226 9.9k
Markus Glatzel 5.5k 0.8× 2.4k 0.7× 943 0.4× 217 0.1× 299 0.2× 294 9.7k
David Leppert 2.4k 0.3× 1.1k 0.3× 2.9k 1.2× 3.8k 2.3× 603 0.5× 170 10.5k

Countries citing papers authored by S. Poser

Since Specialization
Citations

This map shows the geographic impact of S. Poser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Poser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Poser more than expected).

Fields of papers citing papers by S. Poser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Poser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Poser. The network helps show where S. Poser may publish in the future.

Co-authorship network of co-authors of S. Poser

This figure shows the co-authorship network connecting the top 25 collaborators of S. Poser. A scholar is included among the top collaborators of S. Poser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Poser. S. Poser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mollenhauer, Brit, Petra Steinacker, Erik Bahn, et al.. (2007). Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies. Neurodegenerative Diseases. 4(5). 366–375. 62 indexed citations
2.
Cepek, Lukas, Petra Steinacker, Brit Mollenhauer, et al.. (2005). Follow-Up Investigations of Tau Protein and S-100B Levels in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease. Dementia and Geriatric Cognitive Disorders. 19(5-6). 376–382. 15 indexed citations
3.
Jacobi, Christian, Sönke Arlt, Hansotto Reiber, et al.. (2005). Immunoglobulins and virus-specific antibodies in patients with Creutzfeldt-Jakob disease*. Acta Neurologica Scandinavica. 111(3). 185–190. 24 indexed citations
4.
Bitsch, Andreas, Alexander Dressel, Hayrettin Tumani, et al.. (2003). Interferon-?-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis. Journal of Neurology. 250(10). 1224–1228. 40 indexed citations
5.
Arlt, Sönke, Anatol Kontush, Inga Zerr, et al.. (2002). Increased Lipid Peroxidation in Cerebrospinal Fluid and Plasma from Patients with Creutzfeldt–Jakob Disease. Neurobiology of Disease. 10(2). 150–156. 25 indexed citations
6.
Hackstein, Holger, Andreas Bitsch, Anette Bohnert, et al.. (2001). Analysis of interleukin-4 receptor α chain variants in multiple sclerosis. Journal of Neuroimmunology. 113(2). 240–248. 16 indexed citations
7.
Völkel, Dirk, Klaus F. Zimmermann, Inga Zerr, et al.. (2001). C‐reactive protein and IL‐6: new marker proteins for the diagnosis of CJD in plasma?. Transfusion. 41(12). 1509–1514. 22 indexed citations
8.
Poser, S., Inga Zerr, Markus Otto, et al.. (2000). Clinical and differential diagnosis of Creutzfeldt-Jakob disease. PubMed. 153–159. 16 indexed citations
9.
Steinhoff, Bernhard J., et al.. (1998). Elektroenzephalographische Charakteristika der Creutzfeldt-Jakobschen Krankheit und ihre Differentialdiagnose. Fortschritte der Neurologie · Psychiatrie. 66(8). 357–365. 6 indexed citations
10.
Zerr, Inga, Monika Bodemer, Olaf Gefeller, et al.. (1998). Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease. Annals of Neurology. 43(1). 32–40. 332 indexed citations
11.
Will, Robert, Annick Alpérovitch, S. Poser, et al.. (1998). Descriptive epidemiology of Creutzfeldt‐Jakob disease in six european countries, 1993–1995. Annals of Neurology. 43(6). 763–767. 133 indexed citations
12.
Zerr, Inga, Marion Helmhold, S. Poser, Victor W. Armstrong, & Thomas Weber. (1996). Apolipoprotein E Phenotype Frequency and Cerebrospinal Fluid Concentration Are Not Associated With Creutzfeldt-Jakob Disease. Archives of Neurology. 53(12). 1233–1238. 17 indexed citations
14.
Rieckmann, Peter, Frank Weber, Stéphan Martin, et al.. (1996). Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. Journal of Neuroimmunology. 64(2). 193–200. 91 indexed citations
15.
Weber, Thomas, et al.. (1991). The use of recombinant antigens in ELISA procedures for the quantification of intrathecally produced HIV-1-specific antibodies. Journal of Immunological Methods. 136(1). 133–137. 5 indexed citations
16.
Poser, S., et al.. (1991). Impact of magnetic resonance imaging (MRI) on the epidemiology of MS. Acta Neurologica Scandinavica. 83(3). 172–175. 7 indexed citations
17.
Kaiser, R., Rüdiger Dörries, W. Lüer, et al.. (1989). Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV. Journal of Neurology. 236(3). 157–160. 31 indexed citations
18.
Poser, S., W. Lüer, D. Eichenlaub, et al.. (1988). Chronic HIV encephalitis — II. clinical aspects. Journal of Molecular Medicine. 66(1). 26–31. 10 indexed citations
19.
Poser, W., et al.. (1975). [Clinical studies on the habitual abuse of bromoureides].. PubMed. 33. 214–8. 1 indexed citations
20.
Poser, S., et al.. (1973). [Technique of electronic data processing in a multicenter study on multiple sclerosis--early experience with an optical mark reader form system (author's transl)].. PubMed. 204(4). 301–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026